|
In
order to improve our
understanding of the
epidemiology and impact of liver
disease and to enhance our
ability to institute effective
means of diagnosis, therapy, and
prevention of liver disease at
the population level, a well
designed research infrastructure
with adequate funding should be
considered a critical success
factor, additionally, an
appropriate personnel with
necessary qualification and
expertise is the
key ingredient to accomplish
such objectives.
Although
some of these pieces are already
in place, continued commitment
and support for all parties
involved are necessary to move
the field forward.
Results of such project will
best inform policy-making
decisions for formulating
guidelines for the diagnosis,
treatment, and prevention of
liver disease, as well as
resource allocation.
SOLID study network will bring
together all participated
medical centers with expertise
in caring for patients with
liver diseases to conduct
research on hepatitis B,
hepatitis C, Hepatocellular
carcinoma, and Non-alcoholic
fatty liver
diseases to establish a database
of clinical information from a
significant size of chronic
liver disease population from across
both participated countries so as to facilitate
our research and to perform
clinical, epidemiological, and
therapeutic trials and
assessments for these important
liver diseases.
The integrity of involved
parties will, of course, yield a
significant database, resulting
in better understanding and
informed judgments and decisions
about the appropriate hepatic
care and develop effective
treatment strategies along with
the currently available
therapies to reduce disease
related morbidity and mortality
rates. |
